Get App Open
In App
Credit Cards
Open App
you are here:

Eris Lifesciences Ltd.

BSE: 540596 | NSE: ERIS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE406M01024 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Oct 01, 16:01
1622.00 33.50 (2.11%)
Volume
AVERAGE VOLUME
5-Day
14,297
10-Day
12,305
30-Day
34,495
3,036
  • Prev. Close

    1588.50

  • Open Price

    1649.95

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Oct 01, 15:44
1624.90 39.00 (2.46%)
Volume
AVERAGE VOLUME
5-Day
249,268
10-Day
212,591
30-Day
244,631
66,608
  • Prev. Close

    1585.90

  • Open Price

    1585.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

Financials

Profit & Loss account of Eris Lifesciences (in Rs. Cr.) Mar 25 Mar 24 Mar 23 Mar 22 Mar 21  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 1,663.63 1,454.75 1,307.12 1,193.77 1,088.65  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 0.00 0.00 0.00  
Revenue From Operations [Net] 1,663.63 1,454.75 1,307.12 1,193.77 1,088.65  
Total Operating Revenues 1,697.75 1,486.71 1,330.73 1,215.73 1,108.83  
Other Income 35.51 34.83 17.26 28.99 10.00  
Total Revenue 1,733.26 1,521.53 1,347.99 1,244.72 1,118.83  
EXPENSES  
Cost Of Materials Consumed 68.35 96.29 114.13 117.57 99.43  
Purchase Of Stock-In Trade 474.44 197.02 113.76 79.59 111.65  
Operating And Direct Expenses 0.00 0.00 0.00 0.00 0.00  
Changes In Inventories Of FG,WIP And Stock-In Trade -43.54 -13.15 8.50 2.49 -12.57  
Employee Benefit Expenses 361.92 331.67 252.52 222.18 207.02  
Finance Costs 220.24 57.42 20.81 2.99 0.78  
Depreciation And Amortisation Expenses 181.77 102.39 64.66 51.46 37.64  
Other Expenses 350.03 421.06 336.71 309.90 285.99  
Total Expenses 1,613.21 1,192.70 911.08 786.18 729.94  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 120.05 328.83 436.91 458.54 388.89  
Exceptional Items 0.00 0.00 0.00 0.00 0.00  
Profit/Loss Before Tax 120.05 328.83 436.91 458.54 388.89  
Tax Expenses-Continued Operations  
Current Tax 21.98 57.64 76.50 80.17 70.18  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 0.00  
Deferred Tax 20.68 -28.52 -37.59 -38.83 -31.90  
Tax For Earlier Years 0.00 0.00 0.00 0.00 0.00  
Total Tax Expenses 42.66 29.12 38.90 41.35 38.29  
Profit/Loss After Tax And Before ExtraOrdinary Items 77.39 299.71 398.01 417.19 350.61  
Profit/Loss From Continuing Operations 77.39 299.71 398.01 417.19 350.61  
Profit/Loss For The Period 77.39 299.71 398.01 417.19 350.61  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 5.69 22.04 29.27 30.70 25.82  
Diluted EPS (Rs.) 5.68 22.01 29.23 30.70 25.80  
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS  
Imported Raw Materials 0.00 0.00 0.00 0.00 0.00  
Indigenous Raw Materials 0.00 0.00 0.00 0.00 0.00  
STORES, SPARES AND LOOSE TOOLS  
Imported Stores And Spares 0.00 0.00 0.00 0.00 0.00  
Indigenous Stores And Spares 0.00 0.00 0.00 0.00 0.00  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 100.06 0.00 99.93 81.65 74.68  
Tax On Dividend 0.00 0.00 0.00 0.00 0.00  
Equity Dividend Rate (%) 735.00 0.00 735.00 601.00 550.00  
Source : Dion Global Solutions Limited

Results of Pharmaceuticals & Drugs Sector

  • 01.01.1970

  • 01.01.1970

  • 01.01.1970

  • 01.01.1970